Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Akanocure Pharmaceuticals
company
About
Akanocure is a drug development company with a focus on orphan and unmet needs in oncology.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $800K
- Industries
- Health Care,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Metastasis is the spread of cancer to surrounding tissues and distant organs. It is responsible for 90% of cancer deaths. Medical efforts usually fail in managing the disease once it spreads through the body. Akanocure's mission is to find therapeutic approaches that block metastatic processes. The team at Akanocure is applying the expertise of its members throughout the drug discovery and development process to create novel small molecules that will positively impact the lives of cancer patients.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$1.33M
Akanocure Pharmaceuticals has raised a total of
$1.33M
in funding over 2 rounds. Their latest funding was raised on
Jan 27, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 27, 2021 | Grant | $256K | 1 |
National Science Foundation
|
— | Detail |
| Mar 18, 2020 | Grant | $800K | 1 |
National Science Foundation
|
— | Detail |
| Jan 1, 2018 | Grant | $225K | 1 |
National Science Foundation
|
— | Detail |
| May 22, 2017 | Pre-seed | $50K | 1 |
Purdue Ag-celerator
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
4
2
Akanocure Pharmaceuticals is funded by 2 investors.
National Science Foundation
and Purdue Ag-celerator
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
|
Purdue Ag-celerator
|
Yes | Pre-seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
